SPONSOR
Institute of Cancer Research, United Kingdom
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Ovarian Cancer RecurrentAdenocarcinomaProstate CancerProstate BiopsyGenetic CounsellingGenetic Markers
Institute of Cancer Research, United Kingdom is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Ovarian Cancer Recurrent, Adenocarcinoma, Prostate Cancer, Prostate Biopsy.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institute of Cancer Research, United Kingdom
How many clinical trials has Institute of Cancer Research, United Kingdom sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Institute of Cancer Research, United Kingdom, of which 3 are actively recruiting participants. These trials cover conditions including Ovarian Cancer Recurrent, Adenocarcinoma, Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institute of Cancer Research, United Kingdom research focus on?
Institute of Cancer Research, United Kingdom clinical trials span Ovarian Cancer Recurrent, Adenocarcinoma, Prostate Cancer, Prostate Biopsy, Genetic Counselling, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institute of Cancer Research, United Kingdom clinical trial?
To participate in a Institute of Cancer Research, United Kingdom trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institute of Cancer Research, United Kingdom trials with current recruitment status updated daily.
Clinical Trials by Institute of Cancer Research, United Kingdom
NCT05990192 Phase 2
Recruiting
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Ovarian Cancer Recurrent
NCT02973828
Recruiting
PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
Adenocarcinoma
NCT02543905
Recruiting
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology